Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · IEX Real-Time Price · USD
4.380
+0.150 (3.55%)
Apr 26, 2024, 2:47 PM EDT - Market open
Applied Therapeutics Market Cap
Applied Therapeutics has a market cap or net worth of $500.38 million as of April 26, 2024. Its market cap has increased by 973.78% in one year.
Market Cap
500.38M
Enterprise Value
433.81M
1-Year Change
973.78%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since May 14, 2019, Applied Therapeutics's market cap has increased from $160.30M to $500.38M, an increase of 212.15%. That is a compound annual growth rate of 25.84%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 447.90M | -1.86% |
Apr 24, 2024 | 456.40M | -3.37% |
Apr 23, 2024 | 472.30M | 1.13% |
Apr 22, 2024 | 467.00M | 0.69% |
Apr 19, 2024 | 463.80M | -7.59% |
Apr 18, 2024 | 501.90M | -1.86% |
Apr 17, 2024 | 511.40M | -6.22% |
Apr 16, 2024 | 545.30M | 1.77% |
Apr 15, 2024 | 535.80M | -1.94% |
Apr 12, 2024 | 546.40M | -3.36% |
Apr 11, 2024 | 565.40M | -2.92% |
Apr 10, 2024 | 582.40M | -1.25% |
Apr 9, 2024 | 589.80M | -1.59% |
Apr 8, 2024 | 599.30M | -2.08% |
Apr 5, 2024 | 612.00M | -2.38% |
Apr 4, 2024 | 626.90M | -4.67% |
Apr 3, 2024 | 657.60M | -2.51% |
Apr 2, 2024 | 674.50M | 0.63% |
Apr 1, 2024 | 670.30M | -6.90% |
Mar 28, 2024 | 720.00M | -0.73% |
Mar 27, 2024 | 725.30M | 2.69% |
Mar 26, 2024 | 706.30M | -1.18% |
Mar 25, 2024 | 714.70M | - |
Mar 22, 2024 | 714.70M | -1.11% |
Mar 21, 2024 | 722.70M | -1.08% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Fate Therapeutics | 516.73M |
Enhabit | 514.83M |
AnaptysBio | 513.32M |
Alector | 511.30M |
COMPASS Pathways | 511.03M |
UroGen Pharma | 495.79M |
Arbutus Biopharma | 495.48M |
Orthofix Medical | 494.52M |